5-β-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
US7138427B2 · kind B2 · utility
3Cited by
38References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 28, 2002 |
| Grant date | Nov 21, 2006 |
| Priority date | — |
| Expiry date | Jun 5, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J71/0005
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention discloses the use of sapogenin derivatives in the treatment of cognitive disfunction and similar conditions. Methods of treatment and pharmaceutical compositions are also disclosed
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.